Order Article Reprints

Zaizen Y, Nakano M, Fukumori K, Yano Y, Takaki K, Niizeki T, Kuwaki K, Fukahori M, Sakaue T, Yoshimura S, et al. Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Cancers. 2021; 13(21):5282. https://doi.org/10.3390/cancers13215282

Zaizen, Yuki, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Kota Takaki, Takashi Niizeki, Kotaro Kuwaki, Masaru Fukahori, Takahiko Sakaue, Sohei Yoshimura, and et al. 2021. "Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis" Cancers 13, no. 21: 5282. https://doi.org/10.3390/cancers13215282

Zaizen, Y., Nakano, M., Fukumori, K., Yano, Y., Takaki, K., Niizeki, T., Kuwaki, K., Fukahori, M., Sakaue, T., Yoshimura, S., Nakazaki, M., Kuromatsu, R., Okamura, S., Iwamoto, H., Shimose, S., Shirono, T., Noda, Y., Kamachi, N., Koga, H., & Torimura, T. (2021). Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Cancers, 13(21), 5282. https://doi.org/10.3390/cancers13215282